Guglielmo Parisi
Overview
Explore the profile of Guglielmo Parisi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fallico M, Longo A, Avitabile T, Alosi P, Dammino E, Reibaldi M, et al.
Eur J Ophthalmol
. 2025 Mar;
:11206721251319822.
PMID: 40080844
PurposeTo evaluate macular and peripapillary microvascular changes after proton beam radiotherapy for iris melanoma using optical coherence tomography angiography (OCT-A).MethodsPatients treated with proton beam radiotherapy for iris melanoma were included...
2.
Marolo P, Volti G, Nicolosi A, Avitabile T, Longo A, Fallico M, et al.
Retina
. 2025 Feb;
PMID: 39977849
Purpose: To compare intravitreal aflibercept alone versus aflibercept combined with oral anti-inflammatory supplementation in patients with diabetic macular edema (DME). Methods: A prospective, randomized study included 134 treatment-naive eyes with...
3.
Gelormini F, Ricardi F, Parisi G, Vallino V, Ghezzo B, Cucciarelli C, et al.
Invest Ophthalmol Vis Sci
. 2025 Jan;
66(1):31.
PMID: 39804627
Purpose: This study aimed to comprehensively assess visual performance in eyes with idiopathic epiretinal membrane (iERM). Additionally, it sought to explore the associations between optical coherence tomography (OCT) imaging biomarkers...
4.
Ricardi F, Gelormini F, Parisi G, Vallino V, Borrelli E, Marolo P, et al.
Eye (Lond)
. 2024 Oct;
39(2):300-306.
PMID: 39448851
Purpose: To explore the use of autologous platelet-rich plasma (PRP) as a potential therapeutic adjuvant strategy for treating degenerative lamellar macular holes (LMHs). Design: A prospective interventional case series. Methods:...
5.
Marolo P, Caselgrandi P, Fallico M, Parisi G, Borrelli E, Ricardi F, et al.
Acta Ophthalmol
. 2024 Oct;
PMID: 39400983
Purpose: To compare vitrectomy with and without internal limiting membrane (ILM) peeling in small idiopathic macular holes. Methods: Retrospective multicentre study including consecutive eyes with ≤250 μm idiopathic macular hole...
6.
Fallico M, Caselgrandi P, Marolo P, Parisi G, Borrelli E, Ricardi F, et al.
Eye (Lond)
. 2024 Aug;
38(17):3334-3340.
PMID: 39181967
Background: To compare conventional internal limiting membrane (ILM) peeling versus inverted flap technique in small idiopathic macular hole. Methods: Retrospective, multicentre cohort study including consecutive eyes with a ≤250 μm...
7.
Coletto A, Serafino S, Marica V, Olivieri C, Marolo P, Parisi G, et al.
Retin Cases Brief Rep
. 2024 Aug;
PMID: 39168853
Purpose: To report multimodal imaging features of a novel association of non-arteritic anterior ischemic optic neuropathy (NAION), paracentral acute middle maculopathy (PAMM), and cilioretinal artery occlusion (CILRAO). Methods: A 74-year-old...
8.
Olivieri C, Salato M, Campanella A, Marolo P, Parisi G, Neri G, et al.
Acta Diabetol
. 2024 Aug;
62(2):263-269.
PMID: 39160371
Purpose: To compare diabetic retinopathy screening among patients with type 1 or type 2 diabetes under care in two distinct setups: hospital-based multidisciplinary and general practice-based. Materials And Methods: In...
9.
Marolo P, Caselgrandi P, Gaidano M, Conte F, Parisi G, Borrelli E, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124719
This study compared long-term surgical outcomes of the scleral flap versus scleral pocket technique for sutureless intrascleral one-piece intraocular lens (IOL) fixation. : A retrospective comparative study was conducted at...
10.
Borrelli E, Boscia G, Gelormini F, Ricardi F, Ghilardi A, Marolo P, et al.
Eur J Ophthalmol
. 2024 Aug;
35(2):650-659.
PMID: 39094557
Purpose: To assess the associations between visual acuity (VA) and retinal thickness in age-related macular degeneration (AMD) eyes treated with anti-vascular endothelial growth factor (VEGF) therapy. Methods: Sixty-eight patients with...